A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1Keisuke Enomoto(Wakayama Medical University), Muneki Hotomi(Wakayama Medical University)Scientific ReportsOctober 10, 201910.1038/s41598-019-51144-6Cited by 59SaveCiteExport RISWatch citationsRelated PapersSynergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models|Cancers|2021|10MicroRNA 200b promotes mesenchymal‑to‑epithelial transition in anaplastic thyroid carcinoma|Oncology Letters|2020|3